Xu Zi-Di, Zhang Wei, Liu Min, Wang Huan-Min, Hui Pei-Pei, Liang Xue-Jun, Yan Jie, Wu Yu-Jun, Sang Yan-Mei, Zhu Cheng, Ni Gui-Chen
Department of Pediatric Endocrinology, Genetic and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Department of Children Health Care, Xiamen Maternal and Child Health Hospital, Xiamen, China.
Endocr Connect. 2018 Nov 12;7(12):1251-1261. doi: 10.1530/EC-18-0240.
This study aims to summarize and analyze the clinical manifestations, genetic characteristics, treatment modalities and long-term prognosis of congenital hyperinsulinemia (CHI) in Chinese children. Sixty children with CHI, who were treated at Beijing Children's Hospital from January 2014 to August 2017, and their families, were selected as subjects. The CHI-related causative genes in children were sequenced and analyzed using second-generation sequencing technology. Furthermore, the genetic pathogenesis and clinical characteristics of Chinese children with CHI were explored. Among the 60 CHI children, 27 children (27/60, 45%) carried known CHI-related gene mutations: 16 children (26.7%) carried ABCC8 gene mutations, seven children (11.7%) carried GLUD1 gene mutations, one child carried GCK gene mutations, two children carried HNF4α gene mutations and one child carried HADH gene mutations. In these 60 patients, 8 patients underwent 18F-L-DOPA PET scan for the pancreas, and five children were found to be focal type. The treatment of diazoxide was ineffective in these five patients, and hypoglycemia could be controlled after receiving partial pancreatectomy. Conclusions: ABCC8 gene mutation is the most common cause of CHI in Chinese children. The early genetic analysis of children's families has an important guiding significance for treatment planning and prognosis assessment.
本研究旨在总结和分析中国儿童先天性高胰岛素血症(CHI)的临床表现、遗传特征、治疗方式及长期预后。选取2014年1月至2017年8月在北京儿童医院接受治疗的60例CHI患儿及其家庭作为研究对象。采用二代测序技术对患儿CHI相关致病基因进行测序分析。此外,探讨中国CHI患儿的遗传发病机制及临床特征。60例CHI患儿中,27例(27/60,45%)携带已知的CHI相关基因突变:16例(26.7%)携带ABCC8基因突变,7例(11.7%)携带GLUD1基因突变,1例携带GCK基因突变,2例携带HNF4α基因突变,1例携带HADH基因突变。这60例患者中,8例接受了胰腺18F-L-多巴PET扫描,发现5例为局灶型。这5例患者使用二氮嗪治疗无效,接受部分胰腺切除术后低血糖得到控制。结论:ABCC8基因突变是中国儿童CHI最常见的病因。对患儿家庭进行早期基因分析对治疗方案制定和预后评估具有重要指导意义。